✨ Free AI Report
Microbot Medical Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Microbot Medical Inc.
Company Research

Microbot Medical Inc.: Business Overview, Financials & Competitive Analysis

Microbot Medical Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). High-potential endovascular robotics disruptor executing commercial launch with strong IP portfolio, though execution risk remains material until market adoption proves out. The company commenced Limited Market Release in November 2025 with 100% robotic navigation success in a pivotal trial. With $80.2 million in cash and investments as of September.

What is Microbot Medical Inc.'s industry? Microbot Medical Inc. (microbotmedical.com) operates in Medical Device - Surgical Robotics. AskCyborg classifies Microbot Medical Inc. under Medical Device - Surgical Robotics in its company registry.

Microbot Medical is a breakthrough medical device company focused on transforming endovascular procedures through advanced robotic technology, with its LIBERTY® Endovascular Robotic System representing the first singl...

6/ 10Solid

Cyborg Score thesis

High-potential endovascular robotics disruptor executing commercial launch with strong IP portfolio, though execution risk...

Read the full analyst-debate transcript →
Industry Medical Device - Surgical Robotics
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Microbot Medical Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Microbot Medical Inc.

AskCyborg analysts argue the bull and bear cases for Microbot Medical Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Microbot Medical Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Microbot Medical Inc. Overview

Pro stress-test →

Microbot Medical is a breakthrough medical device company focused on transforming endovascular procedures through advanced robotic technology, with its LIBERTY® Endovascular Robotic System representing the first single-use, remotely operated robotic solution designed for precision, efficiency and safety. The company is undergoing a critical transition from a long R&D phase to commercial deployment, with the Limited Market Release commencing in November 2025.

Strategic Profile

Pro stress-test →

The company is betting its future on a single-use, remotely operated robotic system to disrupt the $15 billion endovascular surgery market. Microbot has collaboration agreements with Corewell Health for LIBERTY development and Emory University for autonomous robotics in endovascular procedures.

Competitive Landscape

Pro stress-test →

Key competitors in the robotic surgery and medical device space include Stereotaxis Inc., Ekso Bionics Holdings, Intuitive Surgical, and other surgical robotics firms. Microbot's single-use, disposable design differentiates it from reusable systems, targeting the underserved peripheral endovascular procedure market.

Industry Context

Microbot Medical Inc. operates in Medical Device - Surgical Robotics.

Key facts

Founded: 2010 · Headquarters: Hingham, Massachusetts · Employees: 21 · Revenue: $0 · Market cap: $140.4M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Microbot Medical Inc..

  • Nine-month net loss of $9.68 million through September 2025 reflects pre-commercialization R&D and commercial preparation costs.
  • Emory University Hospital became the first hospital in the world to adopt the LIBERTY System, signaling early validation from prestigious medical institutions.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026LIBERTY System highlighted at leading vascular disease management conference
  • February 2026Limited Market Release on schedule with full market release prepared for Q2 2026
  • +2 moreTrack every material event for Microbot Medical Inc. as it happens. Explore monitoring →
Get alerted when Microbot Medical Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

da Vinci Surgical SystemReusable robotic surgical platform for general surgery and specialties→Niobe ESRobotic navigation system for interventional procedures→EXO-SuitExoskeleton robotics for rehabilitation and mobility→

Compare Microbot Medical Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Microbot Medical Inc. operates in Medical Device - Surgical Robotics. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Device - Surgical Robotics research →
NEW · MCP server

Ask your AI assistant about Microbot Medical Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Microbot Medical Inc. and its top competitor on Cyborg Score”
“What did Microbot Medical Inc. do this quarter?”
“Is Microbot Medical Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Microbot Medical Inc. do?+
Microbot Medical is a breakthrough medical device company focused on transforming endovascular procedures through advanced robotic technology, with its LIBERTY® Endovascular Robotic System representing the first singl...
What is Microbot Medical Inc.'s Cyborg Score?+
Microbot Medical Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Microbot Medical Inc.'s main competitors?+
Named competitors include da Vinci Surgical System, Niobe ES, EXO-Suit. The full competitive landscape is in the AskCyborg report.
How can I get the full Microbot Medical Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Microbot Medical Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Microbot Medical Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.